| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 03/11/2022 | 14:15 | GlobeNewswire Inc. | OraSure Technologies Receives General Clearance for its ORAcollect®•Dx Device for Over-the Counter (OTC) Use from the U.S. Food and Drug Administration (FDA) | NASDAQ:OSUR | OraSure Technologies Inc |
| 02/11/2022 | 12:05 | GlobeNewswire Inc. | InteliSwab® COVID-19 Rapid Test Now Available in Amazon’s Online Store | NASDAQ:OSUR | OraSure Technologies Inc |
| 01/11/2022 | 12:05 | GlobeNewswire Inc. | 2022 Third Quarter Earnings Conference Call Tuesday, November 8, 2022, 5:00 p.m. ET | NASDAQ:OSUR | OraSure Technologies Inc |
| 28/09/2022 | 13:05 | GlobeNewswire Inc. | OraSure Technologies Receives $8.6 Million BARDA Contract to Develop 2nd Generation Ebola Test | NASDAQ:OSUR | OraSure Technologies Inc |
| 20/09/2022 | 22:05 | GlobeNewswire Inc. | OraSure Wins Contract to Supply “Together Take Me Home,” HIV Self-Testing Initiative Sponsored by the Centers for Disease Control and Prevention | NASDAQ:OSUR | OraSure Technologies Inc |
| 14/09/2022 | 13:05 | GlobeNewswire Inc. | OraSure Partners with Mars Petcare in One of the Largest Ever Microbiome Studies to Evaluate Pet Health | NASDAQ:OSUR | OraSure Technologies Inc |
| 31/08/2022 | 14:42 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OSUR | OraSure Technologies Inc |
| 15/08/2022 | 22:12 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:OSUR | OraSure Technologies Inc |
| 12/08/2022 | 22:17 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:OSUR | OraSure Technologies Inc |
| 09/08/2022 | 22:24 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:OSUR | OraSure Technologies Inc |
| 09/08/2022 | 22:05 | GlobeNewswire Inc. | OraSure Reports 2Q22 Record Revenue of $80.2 Million Growing 39% Year-Over-Year | NASDAQ:OSUR | OraSure Technologies Inc |
| 02/08/2022 | 13:05 | GlobeNewswire Inc. | OraSure Technologies to Hold 2022 Second Quarter Earnings Conference Call Tuesday, August 9, 2022, 5:00 p.m. ET | NASDAQ:OSUR | OraSure Technologies Inc |
| 28/07/2022 | 13:05 | GlobeNewswire Inc. | OraSure’s Ongoing Commitment to End the Hepatitis C Epidemic Heats Up at the Racetrack | NASDAQ:OSUR | OraSure Technologies Inc |
| 15/07/2022 | 22:16 | Edgar (US Regulatory) | Amended Current Report Filing (8-k/a) | NASDAQ:OSUR | OraSure Technologies Inc |
| 14/07/2022 | 13:05 | GlobeNewswire Inc. | OraSure Technologies Launches New Product for Microbiome Researchers to Study DNA and RNA | NASDAQ:OSUR | OraSure Technologies Inc |
| 08/06/2022 | 22:05 | GlobeNewswire Inc. | OraSure Technologies Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) | NASDAQ:OSUR | OraSure Technologies Inc |
| 25/05/2022 | 13:51 | Dow Jones News | OraSure Technologies Covid Test Selected by HHS for School Programs | NASDAQ:OSUR | OraSure Technologies Inc |
| 25/05/2022 | 13:05 | GlobeNewswire Inc. | InteliSwab® COVID-19 Rapid Test Selected by Federal Government for Nationwide School Testing | NASDAQ:OSUR | OraSure Technologies Inc |
| 23/05/2022 | 22:05 | GlobeNewswire Inc. | Carrie Eglinton Manner Appointed Chief Executive Officer of OraSure | NASDAQ:OSUR | OraSure Technologies Inc |
| 20/05/2022 | 12:44 | Edgar (US Regulatory) | Securities Registration Statement (simplified Form) (s-3/a) | NASDAQ:OSUR | OraSure Technologies Inc |
| 17/05/2022 | 13:05 | GlobeNewswire Inc. | InteliSwab® COVID-19 Rapid Test Validated to Detect the Omicron BA.2, BA.2.12.1, BA.3 and BA.5 Subvariants | NASDAQ:OSUR | OraSure Technologies Inc |
| 12/05/2022 | 14:15 | TipRanks | Analysts Conflicted on These Healthcare Names: Amicus (FOLD), Orasure Technologies (OSUR) and NanoString Tech (NSTG) | NASDAQ:OSUR | OraSure Technologies Inc |
| 10/05/2022 | 22:05 | GlobeNewswire Inc. | OraSure Reports 1Q22 Record Revenue of $67.7 Million; +16% Year-Over-Year With 21% Growth in Non-COVID Revenue | NASDAQ:OSUR | OraSure Technologies Inc |
| 03/05/2022 | 22:05 | GlobeNewswire Inc. | OraSure Technologies, Inc. 2022 First Quarter Earnings Conference Call Tuesday, May 10, 2022, 5:00 p.m. ET | NASDAQ:OSUR | OraSure Technologies Inc |
| 07/04/2022 | 22:18 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | NASDAQ:OSUR | OraSure Technologies Inc |
| 07/04/2022 | 22:15 | Edgar (US Regulatory) | Proxy Statement (definitive) (def 14a) | NASDAQ:OSUR | OraSure Technologies Inc |
| 07/04/2022 | 13:05 | GlobeNewswire Inc. | OraSure Technologies’ Subsidiary DNA Genotek Launches the First Device with De Novo Authorization from the FDA for the Preservation and Stabilization of Microbiome Samples | NASDAQ:OSUR | OraSure Technologies Inc |
| 31/03/2022 | 13:05 | GlobeNewswire Inc. | OraSure Technologies’ Subsidiary Diversigen Launches Metatranscriptomic Sequencing and Analysis Services for Gut Microbiome Samples | NASDAQ:OSUR | OraSure Technologies Inc |
| 22/03/2022 | 21:05 | GlobeNewswire Inc. | OraSure Director Nancy Gagliano Selected to Serve as Interim Chief Executive Officer; Brings Extensive Diagnostics and Healthcare Leadership Experience to Role | NASDAQ:OSUR | OraSure Technologies Inc |
| 05/03/2022 | 10:09 | TipRanks | Orasure Technologies (OSUR) Receives a Hold from J.P. Morgan | NASDAQ:OSUR | OraSure Technologies Inc |